Fig. 3From: The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivoDynamic analysis of total bacteria copies (a), relative abundance of Clostridium IV (b), Clostridium XIVa (c), Allobaculum spp. (d) and butyryl CoA transferase (BcoA) (e) in feces. *P < 0.05, **P < 0.01, ***P < 0.001 vs NCBack to article page